期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

他汀类药物在呼吸系统疾病中的研究进展 被引量：2

原文传递
导出
摘要 他汀类药物是3-羟基-3-甲基戊二酰辅酶A（HMGCoA）还原酶的抑制剂，是目前最经典和有效的调脂药物，已广泛应用于心脑血管疾病的预防和治疗。新近研究表明，他汀类药物除具有抗动脉粥样硬化作用外，还具有抗炎症反应、抗氧化损伤、免疫调节甚至抑制病原微生物的作用。
作者 曹丽娟 赵瑞贞
机构地区 河北医科大学第三医院胸外科 河北医科大学第三医院呼吸科
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第34期2446-2448,共3页 National Medical Journal of China
关键词 他汀类药物 呼吸系统疾病 抗动脉粥样硬化作用 心脑血管疾病 抗炎症反应 抗氧化损伤 病原微生物 调脂药物
分类号 R96 [医药卫生—药理学]
  • 相关文献

参考文献25

  • 1Chopra V, Flanders SA. Does statin use improve pneumonia outcomes?. Chest, 2009, 136 : 1381-1388.
  • 2Chalmers JD, Singanayagam A, Murray MP, et al. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med, 2008, 121:1002-1007.
  • 3Lee TM, Lin MS, Chang NC. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol, 2008, 101 : 530-535.
  • 4Grosser N, Erdmann K, Hemmerle A, et al. Rosuvastatin npregulates the antioxidant defense protein heine oxygenase-1. Biochem Biophys Res Commun, 2004, 325:871-876.
  • 5Nath N, Gift S, Prasad R, et al. Potential targets of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J Immunol, 2004, 172 : 1273-1286.
  • 6Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. J Antimicrob Chemother, 2008, 61:362-364.
  • 7Ou XM, Wen FQ, Uhal BD, et al. Simvastatin attenuates experimental small airway remodelling in rats. Respirology, 2009, 14:734-745.
  • 8Chen YJ, Chen P, Wang HX, et al. Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras/extracellular signal-regulated kinase pathway. Int Immunopharmacol, 2010, 10:685-693.
  • 9夏书月,康健,姜彦多,黄德生,王实,庞宝森.辛伐他汀对烟雾暴露大鼠肺泡上皮细胞的作用[J].中华结核和呼吸杂志,2010,33(11):806-810. 被引量：6
  • 10Alexeeff SE, Litonjua AA, Sparrow D, et al. Statin use reduces decline in lung function : VA Noimative Aging Study. Am J Respir Crit Care Med, 2007, 176:742-747.

二级参考文献41

  • 1夏熙郑,巨春蓉.Smads蛋白和转化生长因子β_1在大鼠慢性阻塞性肺疾病中的表达[J].中国呼吸与危重监护杂志,2006,5(3):193-197. 被引量：4
  • 2Bellisarii FL, Gallina S, De Caterina R. Tumor nercosis factor- alpha and cardiovascular diseases. Ital Heart J, 2001, 2: 408- 417.
  • 3Nishimura T, Vsazar LT, Faul JL, et al. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation, 2003, 108 : 1640- 1645.
  • 4Nishimura T, Faul JL, Berry GJ, et al. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Am J Respir Crit Care Med, 2002, 166:1403-1408.
  • 5] Murata T, Sato K, Hori M, et al. Decreased endothelial nitricoxide synthase(eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J Biol Chem, 2002, 277: 44085-44092.
  • 6Murata T, Kinoshita K, Hori M, et al. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension. Arterioscler Thromb Vase Biol, 2005, 25 : 2335- 2342.
  • 7Girgis RE, Li D, Zhan X, et al. Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Heart Circ Physiol, 2003, 285 : H938-945.
  • 8Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol, 1994, 144:275- 285.
  • 9Dorfmtiller P, Perros F, Balabaniam K, et al. Inflammation in pulmonary arterial hypertension. Eur Respir J, 2003, 22 : 358- 363.
  • 10Kinlay S. Potential vascular benefits of statins. Am J Med, 2005, 118(Suppl 12A) : 62-67.

共引文献12

同被引文献52

  • 1刘平,张运,王苏加,张风河,郑培惠.冠状动脉粥样硬化性心脏病与牙周病的相关性[J].中国医学科学院学报,2006,28(2):169-172. 被引量：10
  • 2孙芳,陈美云.急性肺损伤/急性呼吸窘迫综合征药物治疗进展[J].国际呼吸杂志,2006,26(11):813-816. 被引量：7
  • 3MeunnanJH, Sanz M,Janket S]. Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oralbiol Med,2004 ,15 :403413.
  • 4DeS tefano F, Anda RF, Kahn HS, et al. Dental disease and risk of coronary heart disease and mortality. BMJ, 1993, 306: 688- 69l.
  • 5Ross R. Atherosclerosis -an inflammatory disease. N EnglJ Med, 1999, 340: ll5-126.
  • 6Lopes- Virella MF, Virella G. Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin Immunol Immunopathol, 1985, 37: 377-386.
  • 7Spahr A, Klein E, Khuseyinova N, et al. Periodontal infections and coronary heart disease: role of periodontal bacteria and import ance of total pathogen burden in the coronary event and periodontal disease (COR-ODONT)study. Arch Intern Med,2006, 166: 554-559.
  • 8Arbes SJ, Slade GD, BeckJD. Association between extene of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES ill dataJ Dent Res, 1999, 78: 1777.
  • 9WilliamsJK, Sukhova GK, Herrington DM, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atheroscleretic monkeys.JAm Coll Cardiol, 1998, 31 :684-691.
  • 10MuhlesteinJB, AndersonJL, CarlquistJF, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation, 2000, 102: 1755-1760.

引证文献2

二级引证文献21

中华医学杂志
2012年 第34期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部